Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-i... Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. 詳細を表示
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
TORONTO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.24 | 10.9090909091 | 2.2 | 2.505 | 2.16 | 25262 | 2.34175916 | CS |
4 | -0.09 | -3.55731225296 | 2.53 | 2.9699 | 2.05 | 22685 | 2.37317153 | CS |
12 | -2.1 | -46.2555066079 | 4.54 | 5 | 2.05 | 25814 | 3.14928076 | CS |
26 | -1.93 | -44.1647597254 | 4.37 | 5.59 | 2.05 | 16618 | 3.53790018 | CS |
52 | -0.92 | -27.380952381 | 3.36 | 6.46 | 2.05 | 17415 | 4.18153373 | CS |
156 | -37.46 | -93.8847117794 | 39.9 | 45.4993 | 2.05 | 106549 | 11.75916996 | CS |
260 | -30.88 | -92.6770708283 | 33.32 | 133.7 | 2.05 | 385057 | 54.28472764 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約